Source: Annual Congress 2002 - Clinical aspects of antibiotic and nonantibiotic therapy of pneumonia in the ICU
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. A. Igonin, V. W. Armstrong, M. Shipkova, V. G. Kukes, M. Oellreich (Moscow, Russia; Goettingen, Germany). Detection of liver function in patients with severe community-acquired pneumonia (CAP). Eur Respir J 2002; 20: Suppl. 38, 227

Member's Comments

No comment yet.

Related content which might interest you: Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2007; 30: Suppl. 51, 42s Year: 2007 Analysis of therapy of community-acquired pneumonia (CAP) at the COPD patients Source: Annual Congress 2011 - COPD management Year: 2011 Enhanced neutrophil response in patients with chronic bronchitis and community-acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 418s Year: 2002 Biomarkers and severity in community-acquired pneumonia (CAP) Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012 Impact of neutrophil function on outcomes of community-acquired pneumonia (CAP) in patients with cancer Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007 Community-acquired pneumonia as a cause of acute respiratory failure (ARF) in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 518s Year: 2005 Characterization of community acquired pneumonia (CAP) with severe sepsis at diagnosis Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Level of hypoferremia at patients with community-acquired pneumonia (CAP) and lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 438s Year: 2007 Community-acquired pneumonia (CAP) in alcoholic patients (AL): differences in aetiology and severity Source: Eur Respir J 2002; 20: Suppl. 38, 560s Year: 2002 Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Legionella pneumonia in patients hospitalized with community-acquired pneumonia (CAP) in Norway Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012 Use of ceftriaxone/sulbactame for treatment of mild-to-severe community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 Etiology of community-acquired pneumonia (CAP) in young hospital patients Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002 Biomarkers in community-acquired pneumonia (CAP) Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Discharge delay in patients with community-acquired pneumonia (CAP) treated with a pneumonia critical pathway Source: Eur Respir J 2002; 20: Suppl. 38, 560s Year: 2002 Definition of severity and the reasons for hospitalization (RH) in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2005; 26: Suppl. 49, 641s Year: 2005 Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Comparison of costs of community-acquired pneumonia (CAP) treatment at patients with and without bronchial obstruction Source: Annual Congress 2011 - COPD management Year: 2011 Mortality in patients with ventilator-associated pneumonia (VAP) and severe sepsis is determined by the number of organ failures Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 Role of viruses, alone and in association with bacteria, in adults hospitalized with community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011